Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement

Edward J. Miller, Roxana Campisi, Nishant R. Shah, Sean McMahon, Sarah Cuddy, Cesia Gallegos-Kattán, Mathew S. Maurer, Thibaud Damy, Riemer H. J. A. Slart, Ketan Bhatia, Andrew J. Einstein